https://medicaex.com/businesswire/bayer-launches-industry-first-public-database-listing-companys-science-collaborations-and-partnerships-in-the-u-s-2/ 2022-12-06T12:12:07+00:00 https://medicaex.com/businesswire/98-of-pharmaceutical-executives-agree-on-importance-of-omnichannel-as-half-of-companies-are-not-optimizing-physician-engagement-across-touchpoints-study-finds-2/ 2022-12-06T12:12:07+00:00 https://medicaex.com/businesswire/exscientia-presents-novel-immuno-oncology-biomarker-for-exs-21546-at-the-esmo-i-o-annual-congress-2/ 2022-12-06T12:12:07+00:00 https://medicaex.com/businesswire/acuitymd-increases-annual-revenue-by-300-customer-and-staff-growth-by-250/ 2022-12-06T12:12:06+00:00 https://medicaex.com/businesswire/endogastric-solutions-inc-announces-ceo-transition-and-18m-financing-to-expand-commercialization/ 2022-12-06T12:12:06+00:00 https://medicaex.com/businesswire/the-worldwide-radiofrequency-ablation-devices-for-pain-management-industry-is-projected-to-reach-1-billion-by-2027-researchandmarkets-com/ 2022-12-06T12:12:06+00:00 https://medicaex.com/businesswire/global-disposable-medical-rubber-market-forecast-to-2029-researchandmarkets-com/ 2022-12-06T12:12:05+00:00 https://medicaex.com/businesswire/avalon-bioventures-raises-first-fund-dedicated-to-early-stage-biotech-investments/ 2022-12-06T12:12:04+00:00 https://medicaex.com/businesswire/genomic-testing-cooperative-to-present-data-at-the-american-society-of-hematology-meeting-on-new-applications-of-its-proprietary-tests-that-combine-transcriptome-data-obtained-from-tissue-or-liquid-bi/ 2022-12-06T12:12:04+00:00 https://medicaex.com/businesswire/bayer-launches-industry-first-public-database-listing-companys-science-collaborations-and-partnerships-in-the-u-s/ 2022-12-06T12:12:04+00:00 https://medicaex.com/businesswire/98-of-pharmaceutical-executives-agree-on-importance-of-omnichannel-as-half-of-companies-are-not-optimizing-physician-engagement-across-touchpoints-study-finds/ 2022-12-06T12:12:04+00:00 https://medicaex.com/businesswire/exscientia-presents-novel-immuno-oncology-biomarker-for-exs-21546-at-the-esmo-i-o-annual-congress/ 2022-12-06T12:12:04+00:00 https://medicaex.com/businesswire/mtti-receives-chinese-patent-for-evathera-technology-2/ 2022-12-06T11:12:08+00:00 https://medicaex.com/businesswire/simbiosys-highlights-key-advances-for-medical-and-surgical-planning-in-breast-cancer-at-sabcs-2022-2/ 2022-12-06T11:12:08+00:00 https://medicaex.com/businesswire/alzheon-announces-early-completion-of-enrollment-of-apolloe4-phase-3-clinical-trial-evaluating-oral-alz-801-valiltramiprosate-in-apoe4-4-homozygotes-with-early-alzheimers-disease-2/ 2022-12-06T11:12:08+00:00 https://medicaex.com/businesswire/nanostring-begins-commercial-shipments-of-cosmx-spatial-molecular-imager-and-atomx-spatial-informatics-platform-2/ 2022-12-06T11:12:08+00:00 https://medicaex.com/businesswire/simbiosys-highlights-key-advances-for-medical-and-surgical-planning-in-breast-cancer-at-sabcs-2022/ 2022-12-06T11:12:07+00:00 https://medicaex.com/businesswire/innovations-in-image-processing-antimicrobial-coatings-wearable-sensors-integrated-pest-management-featuring-tactile-sensing-for-robotic-grippers-more-researchandmarkets-com/ 2022-12-06T11:12:06+00:00 https://medicaex.com/businesswire/nanostring-begins-commercial-shipments-of-cosmx-spatial-molecular-imager-and-atomx-spatial-informatics-platform/ 2022-12-06T11:12:06+00:00 https://medicaex.com/businesswire/mtti-receives-chinese-patent-for-evathera-technology/ 2022-12-06T11:12:06+00:00 https://medicaex.com/businesswire/the-worldwide-lab-consumables-industry-is-projected-to-reach-17-6-billion-by-2027-researchandmarkets-com/ 2022-12-06T11:12:05+00:00 https://medicaex.com/businesswire/global-antivenoms-strategic-business-report-2022-players-include-csl-merck-co-micropharm-and-pfizer-researchandmarkets-com/ 2022-12-06T11:12:04+00:00 https://medicaex.com/businesswire/alzheon-announces-early-completion-of-enrollment-of-apolloe4-phase-3-clinical-trial-evaluating-oral-alz-801-valiltramiprosate-in-apoe4-4-homozygotes-with-early-alzheimers-disease/ 2022-12-06T11:12:04+00:00 https://medicaex.com/businesswire/spectrumx-adds-financial-controller-to-management-team-4/ 2022-12-06T09:12:29+00:00 https://medicaex.com/businesswire/congenica-awarded-second-stage-of-european-contract-to-develop-ngs-analysis-workflow-in-oncology/ 2022-12-06T09:12:27+00:00 https://medicaex.com/wp-content/uploads/2022/12/Congenica_Logo_With_Tagline_RGB-6mRh48.jpeg https://medicaex.com/businesswire/spectrumx-adds-financial-controller-to-management-team-3/ 2022-12-06T09:12:26+00:00 https://medicaex.com/businesswire/spectrumx-adds-financial-controller-to-management-team-2/ 2022-12-06T09:12:25+00:00 https://medicaex.com/businesswire/spectrumx-adds-financial-controller-to-management-team/ 2022-12-06T09:12:23+00:00 https://medicaex.com/businesswire/kkr-to-acquire-clinisupplies-to-accelerate-growth-and-help-build-a-leading-international-chronic-care-medical-devices-platform-2/ 2022-12-06T08:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/KKR_logo-okZu8i.jpeg https://medicaex.com/businesswire/kkr-to-acquire-clinisupplies-to-accelerate-growth-and-help-build-a-leading-international-chronic-care-medical-devices-platform/ 2022-12-06T08:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/KKR_logo-N6s6gW.jpeg https://medicaex.com/businesswire/leo-pharma-announces-positive-phase-3-topline-results-from-delta-1-trial-with-delgocitinib-cream-in-adults-with-moderate-to-severe-chronic-hand-eczema-che/ 2022-12-06T07:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/leopharma-e197sp.jpeg https://medicaex.com/businesswire/mrn-presented-with-the-queens-award-for-enterprise-international-trade-3/ 2022-12-06T06:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/PREVIEW_1B-jiOEl4.jpeg https://medicaex.com/businesswire/mrn-presented-with-the-queens-award-for-enterprise-international-trade-2/ 2022-12-06T06:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/PREVIEW_1B-cm0qWG.jpeg https://medicaex.com/businesswire/mrn-presented-with-the-queens-award-for-enterprise-international-trade/ 2022-12-06T06:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/PREVIEW_1B-mxt8u1.jpeg https://medicaex.com/businesswire/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-4/ 2022-12-05T23:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/4357884cpuma_logo_JPEG-RXSxIA.jpeg https://medicaex.com/businesswire/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-3/ 2022-12-05T23:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/4357884cpuma_logo_JPEG-TSdflY.jpeg https://medicaex.com/businesswire/mei-pharma-initiates-strategic-realignment-2/ 2022-12-05T22:12:08+00:00 https://medicaex.com/businesswire/mei-pharma-and-kyowa-kirin-announce-discontinuation-of-zandelisib-development-outside-of-japan-following-recent-fda-meeting-2/ 2022-12-05T22:12:08+00:00 https://medicaex.com/businesswire/quanterixs-simoa-technology-drives-advances-in-alzheimers-disease-research-presented-at-2022-clinical-trials-on-alzheimers-disease-ctad-conference-2/ 2022-12-05T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Quanterix_Logo-1TirXw.jpeg https://medicaex.com/businesswire/quanterixs-simoa-technology-drives-advances-in-alzheimers-disease-research-presented-at-2022-clinical-trials-on-alzheimers-disease-ctad-conference/ 2022-12-05T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Quanterix_Logo-ROvc0c.jpeg https://medicaex.com/businesswire/mei-pharma-initiates-strategic-realignment/ 2022-12-05T22:12:04+00:00 https://medicaex.com/businesswire/mei-pharma-and-kyowa-kirin-announce-discontinuation-of-zandelisib-development-outside-of-japan-following-recent-fda-meeting/ 2022-12-05T22:12:04+00:00 https://medicaex.com/businesswire/aurinia-reports-new-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-12-05T21:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/12/aurina_logo-OOcIr6.jpeg https://medicaex.com/businesswire/conmed-corporation-announces-quarterly-cash-dividend-2/ 2022-12-05T21:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/12/ConMed_LogoPMS3005_RGB-3FCNQQ.jpeg https://medicaex.com/businesswire/conmed-corporation-announces-quarterly-cash-dividend/ 2022-12-05T21:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/ConMed_LogoPMS3005_RGB-v0umT6.jpeg https://medicaex.com/businesswire/aurinia-reports-new-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-12-05T21:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/aurina_logo-QDM2EJ.jpeg https://medicaex.com/businesswire/spectrum-pharmaceuticals-announces-new-employment-inducement-grants-for-commercial-staff/ 2022-12-05T21:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/NEW_Logo_Spectrum-fbUmRL.jpeg https://medicaex.com/businesswire/a-new-study-in-the-proceedings-of-the-national-academy-of-sciences-pnas-demonstrates-the-ability-of-a-novel-peptide-to-selectively-detect-and-neutralize-an-early-molecular-trigger-of-alzheimer-2/ 2022-12-05T20:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/AltPep_grey_redline_M-HTiODX.jpeg https://medicaex.com/businesswire/call-for-presentations-open-for-the-2023-devicetalks-boston-conference-expo/ 2022-12-05T20:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/wtwh_png-LXeZCM.jpeg https://medicaex.com/businesswire/a-new-study-in-the-proceedings-of-the-national-academy-of-sciences-pnas-demonstrates-the-ability-of-a-novel-peptide-to-selectively-detect-and-neutralize-an-early-molecular-trigger-of-alzheimer/ 2022-12-05T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/AltPep_grey_redline_M-NCaVGu.jpeg https://medicaex.com/businesswire/immune-checkpoint-inhibitors-global-market-report-2022-rising-prevalence-of-cancer-boosts-sector-growth-researchandmarkets-com-2/ 2022-12-05T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-ObLXtV.jpeg https://medicaex.com/businesswire/global-pharma-biotech-and-diagnostics-option-and-evaluation-partnership-terms-and-agreements-report-2022-researchandmarkets-com-2/ 2022-12-05T19:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-DqcCSt.jpeg https://medicaex.com/businesswire/immune-checkpoint-inhibitors-global-market-report-2022-rising-prevalence-of-cancer-boosts-sector-growth-researchandmarkets-com/ 2022-12-05T19:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-7LVwWe.jpeg https://medicaex.com/businesswire/global-pharma-biotech-and-diagnostics-option-and-evaluation-partnership-terms-and-agreements-report-2022-researchandmarkets-com/ 2022-12-05T19:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-zrk8tM.jpeg https://medicaex.com/businesswire/bioconsortia-unveils-broadened-nematicide-seed-treatment-pipeline/ 2022-12-05T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Bioconsortia_greenhouse_photo_testing_plants_in_various_soils-4pwaUx.jpeg https://medicaex.com/businesswire/amber-specialty-pharmacy-named-partner-of-weinfuses-specialty-pharmacy-connect-program-2/ 2022-12-05T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/AmberLogo_RGB-o2mAbO.jpeg https://medicaex.com/businesswire/endoluxe-announces-know-how-agreement-with-mayo-clinic/ 2022-12-05T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Endoluxe_Logo-YiEeTP.jpeg https://medicaex.com/businesswire/global-at-home-self-testing-kits-market-report-2022-to-2035-by-type-of-test-format-type-of-biofluid-analyzed-therapeutic-area-and-key-geographical-regions-researchandmarkets-com/ 2022-12-05T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-OhVvIZ.jpeg https://medicaex.com/businesswire/worldwide-rare-kidney-diseases-industry-report-to-2035-key-market-trends-and-forecasts-researchandmarkets-com/ 2022-12-05T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-BDVu7v.jpeg https://medicaex.com/businesswire/amber-specialty-pharmacy-named-partner-of-weinfuses-specialty-pharmacy-connect-program/ 2022-12-05T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/AmberLogo_RGB-NDZerG.jpeg https://medicaex.com/businesswire/acticor-biotech-receives-european-medicines-agency-ema-endorsement-on-key-parameters-of-actisave-its-pivotal-phase-ii-iii-study-for-registration-in-stroke-2/ 2022-12-05T17:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/12/Acticor-Biotech-Logo-Main-Version-Large-2-cDgDCa.jpeg https://medicaex.com/businesswire/karl-storz-announces-new-sponsorship-to-help-connect-ems-providers-with-grant-application-and-funding-resources-for-research-and-patient-care-2/ 2022-12-05T17:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/STORZ-ENDOSKOPE-NODIA-KSBLUE-HR-zvNCv5.jpeg https://medicaex.com/businesswire/george-mason-advances-tech-start-ups-in-bioscience-cyber-security-sustainability-and-medical-device/ 2022-12-05T17:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/AIC_Logo_2022_Hi_Res-QDBOKk.jpeg https://medicaex.com/businesswire/karl-storz-announces-new-sponsorship-to-help-connect-ems-providers-with-grant-application-and-funding-resources-for-research-and-patient-care/ 2022-12-05T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/STORZ-ENDOSKOPE-NODIA-KSBLUE-HR-nKT27M.jpeg https://medicaex.com/businesswire/acticor-biotech-receives-european-medicines-agency-ema-endorsement-on-key-parameters-of-actisave-its-pivotal-phase-ii-iii-study-for-registration-in-stroke/ 2022-12-05T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Acticor-Biotech-Logo-Main-Version-Large-2-7Lttxj.jpeg https://medicaex.com/businesswire/mrna-therapeutics-and-mrna-vaccines-market-report-2022-significant-rises-in-healthcare-expenditure-drive-growth-researchandmarkets-com/ 2022-12-05T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-uDytxb.jpeg https://medicaex.com/businesswire/panini-launches-biocred-in-future-branches-a-revolutionary-platform-for-secure-in-presence-applications-2/ 2022-12-05T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/IMG_7527-7fXQpW.jpeg https://medicaex.com/businesswire/global-next-generation-sequencing-data-analysis-market-report-2022-introduction-of-technological-advancements-in-cloud-computing-and-data-integration-bodes-well-for-sector-researchandmarkets-com/ 2022-12-05T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-WF3mf2.jpeg https://medicaex.com/businesswire/fresenius-kabi-introduces-kabicare-nutrition-resources-for-u-s-parenteral-nutrition-products-2/ 2022-12-05T16:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo-CT1Hnm.jpeg https://medicaex.com/businesswire/general-inception-announces-strategic-partnership-with-satt-paris-saclay-to-ignite-company-formation-with-renowned-french-research-laboratories-2/ 2022-12-05T16:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/GI_Logo_Main_black_28129-LblhDj.jpeg https://medicaex.com/businesswire/panini-launches-biocred-in-future-branches-a-revolutionary-platform-for-secure-in-presence-applications/ 2022-12-05T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/IMG_7527-RXkJhA.jpeg https://medicaex.com/businesswire/general-inception-announces-strategic-partnership-with-satt-paris-saclay-to-ignite-company-formation-with-renowned-french-research-laboratories/ 2022-12-05T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/GI_Logo_Main_black_28129-uFt41P.jpeg https://medicaex.com/businesswire/fresenius-kabi-introduces-kabicare-nutrition-resources-for-u-s-parenteral-nutrition-products/ 2022-12-05T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo-i35QjC.jpeg https://medicaex.com/businesswire/eurofins-launches-bq-1-and-bq-1-1-droplet-digital-pcr-assay-ddpcr-for-sars-cov-2-wastewater-testing-3/ 2022-12-05T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/12/EUROFINS_jpg-1x5idQ.jpeg https://medicaex.com/businesswire/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate-2/ 2022-12-05T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/12/Vaxxas_logo_bigger-kqgaQT.jpeg https://medicaex.com/businesswire/global-oligonucleotide-synthesis-global-market-report-2022-increasing-use-of-synthesized-oligos-in-therapeutic-applications-boosts-growth-researchandmarkets-com-2/ 2022-12-05T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-aTB3zY.jpeg https://medicaex.com/businesswire/fractyl-health-announced-positive-proof-of-concept-data-of-pancreatic-glp-1-gene-therapy-in-a-type-2-diabetes-animal-model-at-the-20th-world-congress-on-insulin-resistance-diabetes-cardiovascul-2/ 2022-12-05T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/12/Fractyl-Logo-mksav3.jpeg https://medicaex.com/businesswire/global-nutraceutical-ingredients-market-report-2022-mandates-on-food-fortification-by-government-organizations-driving-growth-researchandmarkets-com/ 2022-12-05T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-faBO0U.jpeg https://medicaex.com/businesswire/xponential-fitness-signs-master-franchise-agreement-in-japan-for-rumble-and-akt/ 2022-12-05T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/xponential-1-color-black-horizontal-logo-cY9irU.jpeg https://medicaex.com/businesswire/flow-cytometry-in-oncology-and-immunology-global-market-report-2022-expansion-of-applications-in-flow-cytometry-for-research-activities-propels-its-demand-researchandmarkets-com-2/ 2022-12-05T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-ikGAnk.jpeg https://medicaex.com/businesswire/wilson-sonsini-goodrich-rosati-elects-18-new-partners-2/ 2022-12-05T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/WSGR_logo-LLgdsw.jpeg https://medicaex.com/businesswire/eurofins-launches-bq-1-and-bq-1-1-droplet-digital-pcr-assay-ddpcr-for-sars-cov-2-wastewater-testing-2/ 2022-12-05T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/EUROFINS_jpg-dezSFf.jpeg https://medicaex.com/businesswire/fractyl-health-announced-positive-proof-of-concept-data-of-pancreatic-glp-1-gene-therapy-in-a-type-2-diabetes-animal-model-at-the-20th-world-congress-on-insulin-resistance-diabetes-cardiovascul/ 2022-12-05T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/Fractyl-Logo-nDljuw.jpeg https://medicaex.com/businesswire/global-ophthalmic-handheld-surgical-instruments-market-report-2022-to-2030-players-include-bvi-accutome-katena-products-and-asico-researchandmarkets-com/ 2022-12-05T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-MXyBPI.jpeg https://medicaex.com/businesswire/eurofins-launches-bq-1-and-bq-1-1-droplet-digital-pcr-assay-ddpcr-for-sars-cov-2-wastewater-testing/ 2022-12-05T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/EUROFINS_jpg-DuEpsO.jpeg https://medicaex.com/businesswire/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate/ 2022-12-05T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Vaxxas_logo_bigger-5R1xZ7.jpeg https://medicaex.com/businesswire/global-oligonucleotide-synthesis-global-market-report-2022-increasing-use-of-synthesized-oligos-in-therapeutic-applications-boosts-growth-researchandmarkets-com/ 2022-12-05T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-LeYxF9.jpeg https://medicaex.com/businesswire/wilson-sonsini-goodrich-rosati-elects-18-new-partners/ 2022-12-05T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/WSGR_logo-xZQR3B.jpeg https://medicaex.com/businesswire/flow-cytometry-in-oncology-and-immunology-global-market-report-2022-expansion-of-applications-in-flow-cytometry-for-research-activities-propels-its-demand-researchandmarkets-com/ 2022-12-05T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-LfXB0f.jpeg https://medicaex.com/businesswire/agendia-spotlights-the-future-of-personalized-breast-cancer-care-at-2022-san-antonio-breast-cancer-symposium/ 2022-12-05T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/Agendia_Logo_-_600x600_2800229-Hq5BSa.jpeg https://medicaex.com/businesswire/immuneoncia-announces-phase-2-results-of-pd-l1-immune-checkpoint-inhibitor-at-esmo-asia-2/ 2022-12-05T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/IO_logo-clS2xF.jpeg https://medicaex.com/businesswire/mammoth-biosciences-announces-appointment-of-phil-tinmouth-siang-chin-to-key-leadership-roles-2/ 2022-12-05T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/Mammoth_Logo-emdSWS.jpeg https://medicaex.com/businesswire/bioage-announces-positive-topline-results-for-bge-105-in-phase-1b-clinical-trial-evaluating-muscle-atrophy-in-older-volunteers-at-bed-rest-2/ 2022-12-05T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo_for_business_wire-RaBPDl.jpeg https://medicaex.com/businesswire/zephyr-ai-announces-formation-of-scientific-and-medical-advisory-board-3/ 2022-12-05T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/Zephyr-AI-gdPm1i.jpeg https://medicaex.com/businesswire/purivitae-ventures-to-acquire-home-fitness-innovator-quadropress/ 2022-12-05T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/Purivitae-Horizontal-RGB-PNG-DMEruj.jpeg https://medicaex.com/businesswire/dawn-health-the-leading-virtual-insomnia-clinic-raises-strategic-capital-to-expand-as-full-stack-provider-2/ 2022-12-05T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Screen_Shot_2022-09-19_at_7.20.51_PM-QZP8I4.jpeg https://medicaex.com/businesswire/fortive-announces-appointment-of-eric-branderiz-to-its-board-of-directors/ 2022-12-05T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Fortive_Logo-p2RbEl.jpeg https://medicaex.com/businesswire/mammoth-biosciences-announces-appointment-of-phil-tinmouth-siang-chin-to-key-leadership-roles/ 2022-12-05T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Mammoth_Logo-gElspm.jpeg https://medicaex.com/businesswire/zephyr-ai-announces-formation-of-scientific-and-medical-advisory-board-2/ 2022-12-05T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Zephyr-AI-lB0FWz.jpeg https://medicaex.com/businesswire/rockley-photonics-ceo-andrew-rickman-to-speak-at-the-commonwealth-trade-and-investment-summit-2022/ 2022-12-05T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Rockley-logo-500-x-500-mknKlG.jpeg https://medicaex.com/businesswire/ruling-by-german-social-court-supports-myopro-reimbursement-by-nations-statutory-health-insurance-system/ 2022-12-05T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Myomo_tag_28529-QSwbEq.jpeg https://medicaex.com/businesswire/from-feline-genetics-startup-to-pet-genetics-leader-top-shark-kevin-olearys-all-time-favorite-product-basepaws-reappears-on-shark-tank-with-big-updates/ 2022-12-05T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Basepaws_on_Shark_Tank_Dec._22C_2022-U1JvVH.jpeg https://medicaex.com/businesswire/the-worldwide-advanced-wound-care-industry-is-expected-to-reach-13-billion-by-2028-researchandmarkets-com/ 2022-12-05T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-GRKqHh.jpeg https://medicaex.com/businesswire/merrimack-pharmaceuticals-extends-section-382-net-operating-loss-rights-plan/ 2022-12-05T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/MACK_Logo_12.2.19-owCuEn.jpeg https://medicaex.com/businesswire/bioage-announces-positive-topline-results-for-bge-105-in-phase-1b-clinical-trial-evaluating-muscle-atrophy-in-older-volunteers-at-bed-rest/ 2022-12-05T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo_for_business_wire-boMNEp.jpeg https://medicaex.com/businesswire/hims-hers-appoints-first-ever-chief-pharmacy-innovation-officer-2/ 2022-12-05T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Headshot_2022-kBAocI.jpeg https://medicaex.com/businesswire/zephyr-ai-announces-formation-of-scientific-and-medical-advisory-board/ 2022-12-05T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Zephyr-AI-TGvAcG.jpeg https://medicaex.com/businesswire/hims-hers-appoints-first-ever-chief-pharmacy-innovation-officer/ 2022-12-05T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Headshot_2022-BcXMhn.jpeg https://medicaex.com/businesswire/immuneoncia-announces-phase-2-results-of-pd-l1-immune-checkpoint-inhibitor-at-esmo-asia/ 2022-12-05T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/IO_logo-7nS56T.jpeg https://medicaex.com/businesswire/dawn-health-the-leading-virtual-insomnia-clinic-raises-strategic-capital-to-expand-as-full-stack-provider/ 2022-12-05T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Screen_Shot_2022-09-19_at_7.20.51_PM-ozAGN8.jpeg https://medicaex.com/businesswire/aviceda-announces-successful-completion-of-key-ind-toxicity-milestone-with-favorable-safety-profile-in-non-human-primates-2/ 2022-12-05T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/AVICEDA_THERAPEUTICS_LOGO_MASTER-o51ZeW.jpeg https://medicaex.com/businesswire/worldwide-clinical-trials-appoints-pete-duprat-as-sr-vice-president-commercial-early-phase-2/ 2022-12-05T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Pete_Duprat-YN0i7j.jpeg https://medicaex.com/businesswire/celularity-announces-halal-certification-of-its-advanced-cellular-therapeutics-biomaterial-products-and-business-model/ 2022-12-05T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/celularity-horizontal-fullcolor-1JUbmW.jpeg https://medicaex.com/businesswire/endra-life-sciences-announces-1-for-20-reverse-stock-split-2/ 2022-12-05T13:12:09+00:00 https://medicaex.com/businesswire/the-u-s-weight-loss-market-a-statistical-profile-data-pack-researchandmarkets-com/ 2022-12-05T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-KihLD9.jpeg https://medicaex.com/businesswire/ipa-to-report-financial-results-and-recent-business-highlights-for-second-quarter-fiscal-year-2023-on-december-15-2022-3/ 2022-12-05T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/IPA_Tagline_Gray_lg-RGB-lyArob.jpeg https://medicaex.com/businesswire/first-patients-in-the-world-treated-with-impella-rp-flex-with-smartassist-2/ 2022-12-05T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/RP_Flex_with_SmartAssist_Illustration_01-qLQjyR.jpeg https://medicaex.com/businesswire/agilent-opens-customer-experience-center-highlighting-genomics-and-diagnostics-solutions/ 2022-12-05T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Agilent_Logo_Tag_v_RGB-lIwjYF.jpeg https://medicaex.com/businesswire/perimeter-medical-imaging-ai-announces-publication-of-peer-reviewed-journal-article-validating-potential-use-of-wide-field-optical-coherence-tomography-wf-oct-in-head-and-neck-surgeries-2/ 2022-12-05T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Perimeter_Logo-25YhxU.jpeg https://medicaex.com/businesswire/ipa-to-report-financial-results-and-recent-business-highlights-for-second-quarter-fiscal-year-2023-on-december-15-2022-2/ 2022-12-05T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/IPA_Tagline_Gray_lg-RGB-To3Uce.jpeg https://medicaex.com/businesswire/braintale-has-presented-the-interest-if-its-digital-biomarkers-platform-in-differential-diagnosis-during-the-15th-edition-of-clinical-trials-on-alzheimers-disease-conference/ 2022-12-05T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo2022-wjqkzF.jpeg https://medicaex.com/businesswire/perimeter-medical-imaging-ai-announces-publication-of-peer-reviewed-journal-article-validating-potential-use-of-wide-field-optical-coherence-tomography-wf-oct-in-head-and-neck-surgeries/ 2022-12-05T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/Perimeter_Logo-UEGbXm.jpeg https://medicaex.com/businesswire/first-patients-in-the-world-treated-with-impella-rp-flex-with-smartassist/ 2022-12-05T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/RP_Flex_with_SmartAssist_Illustration_01-Nat6LQ.jpeg https://medicaex.com/businesswire/omnicell-to-showcase-advanced-services-designed-to-deliver-enhanced-medication-management-outcomes-at-ashp-midyear-2022/ 2022-12-05T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/01_omnicell_lockup_horizontal_green_rgb-lBsHts.jpeg https://medicaex.com/businesswire/aviceda-announces-successful-completion-of-key-ind-toxicity-milestone-with-favorable-safety-profile-in-non-human-primates/ 2022-12-05T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/AVICEDA_THERAPEUTICS_LOGO_MASTER-D5NrFd.jpeg https://medicaex.com/businesswire/worldwide-clinical-trials-appoints-pete-duprat-as-sr-vice-president-commercial-early-phase/ 2022-12-05T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Pete_Duprat-dD2yFF.jpeg https://medicaex.com/businesswire/endra-life-sciences-announces-1-for-20-reverse-stock-split/ 2022-12-05T13:12:04+00:00 https://medicaex.com/businesswire/ipa-to-report-financial-results-and-recent-business-highlights-for-second-quarter-fiscal-year-2023-on-december-15-2022/ 2022-12-05T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/IPA_Tagline_Gray_lg-RGB-JFtqNT.jpeg https://medicaex.com/businesswire/kalvista-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-12-05T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Kalvista-Logo-Final-01-Y41ycN.jpeg https://medicaex.com/businesswire/ligand-pharmaceuticals-names-director-todd-c-davis-as-ceo-2/ 2022-12-05T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Ligand-Logo-Registered5-4sKTMl.jpeg https://medicaex.com/businesswire/acorda-therapeutics-makes-december-2022-6-2-million-interest-payment-on-secured-debt-in-cash/ 2022-12-05T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Acorda_Logo-Color_Print-If1jjN.jpeg https://medicaex.com/businesswire/kalvista-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-12-05T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Kalvista-Logo-Final-01-3B6GfH.jpeg https://medicaex.com/businesswire/ligand-pharmaceuticals-names-director-todd-c-davis-as-ceo/ 2022-12-05T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Ligand-Logo-Registered5-WjCgCT.jpeg https://medicaex.com/businesswire/syros-to-host-virtual-event-to-discuss-initial-select-aml-1-data-and-unmet-need-in-newly-diagnosed-unfit-acute-myeloid-leukemia-on-december-10/ 2022-12-05T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Syros_Logo-EWzX1X.jpeg https://medicaex.com/businesswire/worldwide-immunoglobulin-industry-to-2028-prevalence-of-immunodeficiency-diseases-and-autoimmune-disorders-is-driving-growth-researchandmarkets-com/ 2022-12-05T11:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-pOnIq1.jpeg https://medicaex.com/businesswire/effective-technology-transfer-training-course-focus-on-pharmaceutical-products-including-atmps-and-combination-products-january-24-25-2023-researchandmarkets-com/ 2022-12-05T10:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-VRfTsa.jpeg https://medicaex.com/businesswire/global-healthcare-additive-manufacturing-market-2022-to-2027-players-include-3d-systems-allevi-ansys-and-basf-researchandmarkets-com/ 2022-12-05T10:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-LrJmIY.jpeg https://medicaex.com/businesswire/bactobio-raises-6-million-to-discover-novel-antimicrobials/ 2022-12-05T09:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/12/BACTOBIO_FullLookup_MidRes-cahGpG.jpeg https://medicaex.com/businesswire/ellipses-pharma-presents-design-of-newly-initiated-phase-1-2a-trial-of-vosilasarm-ep0062-at-sabcs/ 2022-12-05T09:12:08+00:00 https://medicaex.com/businesswire/sensorion-announces-its-attendance-at-the-41st-annual-j-p-morgan-healthcare-meeting-in-san-francisco-2/ 2022-12-05T07:12:08+00:00 https://medicaex.com/businesswire/sensorion-announces-its-attendance-at-the-41st-annual-j-p-morgan-healthcare-meeting-in-san-francisco/ 2022-12-05T07:12:04+00:00 https://medicaex.com/businesswire/novo-nordisk-atlatl-announce-winners-in-their-joint-program-entrestar-2/ 2022-12-05T05:12:07+00:00 https://medicaex.com/businesswire/novo-nordisk-atlatl-announce-winners-in-their-joint-program-entrestar/ 2022-12-05T05:12:03+00:00 https://medicaex.com/businesswire/mindray-introduces-new-wearable-patient-monitoring-system-refining-clinicians-workflow-to-track-patient-conditions-3/ 2022-12-05T04:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/KV-xrrPYK.jpeg https://medicaex.com/businesswire/mindray-introduces-new-wearable-patient-monitoring-system-refining-clinicians-workflow-to-track-patient-conditions-2/ 2022-12-05T04:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/KV-qvrS05.jpeg https://medicaex.com/businesswire/mindray-introduces-new-wearable-patient-monitoring-system-refining-clinicians-workflow-to-track-patient-conditions/ 2022-12-05T04:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/KV-nYZxEp.jpeg https://medicaex.com/businesswire/therapeuticsmd-announces-definitive-agreements-to-license-its-products-to-mayne-pharma-3/ 2022-12-04T23:12:07+00:00 https://medicaex.com/businesswire/pictor-announces-funding-round-after-successful-launch-in-new-zealand-and-usa-of-sars-cov-2-antibody-test-2/ 2022-12-04T23:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/2020_Pictor_Logo_CMYK_colour-wXHaJD.jpeg https://medicaex.com/businesswire/pictor-announces-funding-round-after-successful-launch-in-new-zealand-and-usa-of-sars-cov-2-antibody-test/ 2022-12-04T23:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/2020_Pictor_Logo_CMYK_colour-8oCzXY.jpeg https://medicaex.com/businesswire/therapeuticsmd-announces-definitive-agreements-to-license-its-products-to-mayne-pharma-2/ 2022-12-04T23:12:05+00:00 https://medicaex.com/businesswire/therapeuticsmd-announces-definitive-agreements-to-license-its-products-to-mayne-pharma/ 2022-12-04T23:12:04+00:00 https://medicaex.com/businesswire/swisslog-healthcare-showcases-medication-management-solutions-at-ashp-midyear-clinical-meeting-exhibition-3/ 2022-12-04T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/Swisslog_Logo_Left_-_Red-Purple-5nguFt.jpeg https://medicaex.com/businesswire/swisslog-healthcare-showcases-medication-management-solutions-at-ashp-midyear-clinical-meeting-exhibition-2/ 2022-12-04T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Swisslog_Logo_Left_-_Red-Purple-clk0UI.jpeg https://medicaex.com/businesswire/swisslog-healthcare-showcases-medication-management-solutions-at-ashp-midyear-clinical-meeting-exhibition/ 2022-12-04T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Swisslog_Logo_Left_-_Red-Purple-NgzDSj.jpeg https://medicaex.com/businesswire/announcement-for-the-purposes-of-rule-2-8-of-the-irish-takeover-panel-act-1997-takeover-rules-2022-the-irish-takeover-rules-3/ 2022-12-03T23:12:07+00:00 https://medicaex.com/businesswire/announcement-for-the-purposes-of-rule-2-8-of-the-irish-takeover-panel-act-1997-takeover-rules-2022-the-irish-takeover-rules-2/ 2022-12-03T23:12:06+00:00 https://medicaex.com/businesswire/announcement-for-the-purposes-of-rule-2-8-of-the-irish-takeover-panel-act-1997-takeover-rules-2022-the-irish-takeover-rules/ 2022-12-03T23:12:03+00:00 https://medicaex.com/businesswire/jack-nathan-health-provides-corporate-update/ 2022-12-03T01:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Jack_Nathan_Health_Official_Logo-1ycGSW.jpeg https://medicaex.com/businesswire/selectquote-inc-announces-special-meeting-to-approve-reverse-stock-split/ 2022-12-02T23:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/SLQT_Logo-qNXXKC.jpeg https://medicaex.com/businesswire/atara-biotherapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-4/ 2022-12-02T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Atara-Bio1_logo_300x185-1-5rCRKX.jpeg https://medicaex.com/businesswire/better-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-3/ 2022-12-02T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Better_Tx_640x360_Logo-TXCsqi.jpeg https://medicaex.com/businesswire/astria-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-12-02T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Astria_logo-7z7qBv.jpeg https://medicaex.com/businesswire/better-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-12-02T21:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Better_Tx_640x360_Logo-2Q5xVn.jpeg https://medicaex.com/businesswire/better-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-12-02T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Better_Tx_640x360_Logo-7cvSo3.jpeg https://medicaex.com/businesswire/astria-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-12-02T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Astria_logo-xK8Dkn.jpeg https://medicaex.com/businesswire/atara-biotherapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-3/ 2022-12-02T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Atara-Bio1_logo_300x185-1-B3TCnx.jpeg https://medicaex.com/businesswire/400-million-biological-safety-cabinet-class-i-class-ii-class-iii-markets-global-forecast-to-2027-increased-risk-of-pandemics-and-communicable-diseases-to-drive-market-researchandmarkets-com-4/ 2022-12-02T19:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-NmL5tt.jpeg https://medicaex.com/businesswire/global-inhalation-anesthetics-market-to-reach-1-5-billion-by-2027-at-a-cagr-of-3-7-researchandmarkets-com-3/ 2022-12-02T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-R8gLrj.jpeg https://medicaex.com/businesswire/400-million-biological-safety-cabinet-class-i-class-ii-class-iii-markets-global-forecast-to-2027-increased-risk-of-pandemics-and-communicable-diseases-to-drive-market-researchandmarkets-com-3/ 2022-12-02T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-8H945L.jpeg https://medicaex.com/businesswire/medical-tubing-global-market-report-2022-trend-shift-toward-preventative-healthcare-boosts-sector-researchandmarkets-com-2/ 2022-12-02T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-gufXiu.jpeg https://medicaex.com/businesswire/global-inhalation-anesthetics-market-to-reach-1-5-billion-by-2027-at-a-cagr-of-3-7-researchandmarkets-com-2/ 2022-12-02T19:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-eLL99x.jpeg https://medicaex.com/businesswire/global-inhalation-anesthetics-market-to-reach-1-5-billion-by-2027-at-a-cagr-of-3-7-researchandmarkets-com/ 2022-12-02T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-F3f7Y2.jpeg https://medicaex.com/businesswire/400-million-biological-safety-cabinet-class-i-class-ii-class-iii-markets-global-forecast-to-2027-increased-risk-of-pandemics-and-communicable-diseases-to-drive-market-researchandmarkets-com-2/ 2022-12-02T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-jzD5aT.jpeg https://medicaex.com/businesswire/medical-tubing-global-market-report-2022-trend-shift-toward-preventative-healthcare-boosts-sector-researchandmarkets-com/ 2022-12-02T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-sXJnhx.jpeg https://medicaex.com/businesswire/400-million-biological-safety-cabinet-class-i-class-ii-class-iii-markets-global-forecast-to-2027-increased-risk-of-pandemics-and-communicable-diseases-to-drive-market-researchandmarkets-com/ 2022-12-02T19:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-DCqyvj.jpeg https://medicaex.com/businesswire/worldwide-nanocellulose-industry-to-2027-by-product-type-application-end-use-and-region-researchandmarkets-com/ 2022-12-02T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-f4mh7i.jpeg https://medicaex.com/businesswire/atopic-dermatitis-treatment-global-market-report-2022-increasing-adoption-of-biological-therapies-drives-growth-researchandmarkets-com-2/ 2022-12-02T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-TL840W.jpeg https://medicaex.com/businesswire/global-wireless-medical-device-connectivity-market-to-2027-featuring-baxter-international-bridge-tech-medical-cisco-systems-and-masimo-among-others-researchandmarkets-com-2/ 2022-12-02T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-pXEOXG.jpeg https://medicaex.com/businesswire/five-trinity-health-senior-communities-benefit-from-mdhhs-infection-control-grant-3/ 2022-12-02T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Trinity_Logo-L7xrc9.jpeg https://medicaex.com/businesswire/global-dermatology-medical-lasers-market-2022-to-2031-featuring-cynosure-miracle-laser-syneron-and-shenzhen-gsd-among-others-researchandmarkets-com/ 2022-12-02T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-F4CiUJ.jpeg https://medicaex.com/businesswire/global-wireless-medical-device-connectivity-market-to-2027-featuring-baxter-international-bridge-tech-medical-cisco-systems-and-masimo-among-others-researchandmarkets-com/ 2022-12-02T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-54msTK.jpeg https://medicaex.com/businesswire/five-trinity-health-senior-communities-benefit-from-mdhhs-infection-control-grant-2/ 2022-12-02T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/Trinity_Logo-MSgRY8.jpeg https://medicaex.com/businesswire/five-trinity-health-senior-communities-benefit-from-mdhhs-infection-control-grant/ 2022-12-02T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Trinity_Logo-YmMwvx.jpeg https://medicaex.com/businesswire/atopic-dermatitis-treatment-global-market-report-2022-increasing-adoption-of-biological-therapies-drives-growth-researchandmarkets-com/ 2022-12-02T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-Zqu85n.jpeg https://medicaex.com/businesswire/urogen-announces-new-data-from-the-optima-ii-study-that-show-median-durability-of-response-of-24-4-months-for-ugn-102-an-investigational-non-surgical-chemoablative-treatment-for-low-grade-intermedia-2/ 2022-12-02T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/UroGen_logo2_28R29_2800229-QEnsqi.jpeg https://medicaex.com/businesswire/bostongene-announces-presentations-at-the-64th-american-society-of-hematology-ash-annual-meeting-exposition-2/ 2022-12-02T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/bostongene-logo-3G7UQq.jpeg https://medicaex.com/businesswire/everest-clinical-research-announces-the-acquisition-of-brightech-international-3/ 2022-12-02T17:12:09+00:00 https://medicaex.com/businesswire/global-flow-cytometry-market-report-2022-rise-in-the-adoption-of-the-flow-cytometry-approach-in-academia-and-research-drives-growth-researchandmarkets-com/ 2022-12-02T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-hfsC4B.jpeg https://medicaex.com/businesswire/everest-clinical-research-announces-the-acquisition-of-brightech-international-2/ 2022-12-02T17:12:07+00:00 https://medicaex.com/businesswire/the-garage-enters-strategic-partnership-with-morris-heights-health-center-in-an-effort-to-change-healthcare-in-underserved-bronx-ny/ 2022-12-02T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/garage_logo_big-2mm0Kz.jpeg https://medicaex.com/businesswire/urogen-announces-new-data-from-the-optima-ii-study-that-show-median-durability-of-response-of-24-4-months-for-ugn-102-an-investigational-non-surgical-chemoablative-treatment-for-low-grade-intermedia/ 2022-12-02T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/UroGen_logo2_28R29_2800229-kNasMr.jpeg https://medicaex.com/businesswire/bostongene-announces-presentations-at-the-64th-american-society-of-hematology-ash-annual-meeting-exposition/ 2022-12-02T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/bostongene-logo-3mz59f.jpeg https://medicaex.com/businesswire/everest-clinical-research-announces-the-acquisition-of-brightech-international/ 2022-12-02T17:12:05+00:00 https://medicaex.com/businesswire/global-bacteriophage-therapy-market-report-2022-looming-threat-of-antimicrobial-resistance-drives-research-growth-researchandmarkets-com-2/ 2022-12-02T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-cWc9qb.jpeg https://medicaex.com/businesswire/cell-culture-protein-surface-coatings-global-market-report-2022-increased-efficiency-and-efficacy-driving-adoption-researchandmarkets-com/ 2022-12-02T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-sEBSBT.jpeg https://medicaex.com/businesswire/huntington-medical-research-institutes-to-host-holiday-open-house-commemorating-70th-anniversary-2/ 2022-12-02T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/HMRI_Holiday_Open_House_12.03.22-adVafG.jpeg https://medicaex.com/businesswire/life-science-industry-in-california-generates-376-billion-annually/ 2022-12-02T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/BiocomCaliforniaLogo_Primary-2-m7AM2U.jpeg https://medicaex.com/businesswire/global-nutrigenomics-market-report-2022-to-2035-industry-trends-and-forecasts-researchandmarkets-com/ 2022-12-02T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-nDnBEH.jpeg https://medicaex.com/businesswire/huntington-medical-research-institutes-to-host-holiday-open-house-commemorating-70th-anniversary/ 2022-12-02T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/HMRI_Holiday_Open_House_12.03.22-cwtDNn.jpeg https://medicaex.com/businesswire/375-million-bone-densitometer-dexa-peripheral-markets-increasing-prevalence-of-osteoporosis-to-drive-the-market-for-bone-densitometers-global-forecast-to-2027-researchandmarkets-com/ 2022-12-02T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-8gi09a.jpeg